Titre :
  • Clinical phase I and pharmacokinetic study of S 16020, a new olivacine derivative: report on three infusion schedules.
Auteur : Awada, Ahmad ; Giacchetti, S ; Gérard, B. ; Eftekhary, P ; Lucas, Catherine ; De Valeriola, Dominique ; Poullain, M G ; Soudon, J ; Dosquet, C ; Brillanceau, M-H ; Giroux, B ; Marty, Marianne ; Bleiberg, Harry ; Calvo, F ; Piccart-Gebhart, Martine
Informations sur la publication : Annals of oncology, 13, 12, (page 1925-1934)
Statut de publication : Publié, 2002-12
Sujet CREF : Sciences bio-médicales et agricoles
Mots-clés MeSH : Adult
Aged
Biological Availability
Carbazoles -- administration & dosage
Carbazoles -- adverse effects
Carbazoles -- pharmacokinetics
Dose-Response Relationship, Drug
Drug Administration Schedule
Ellipticines
Female
Follow-Up Studies
Humans
Infusions, Intravenous
Male
Maximum Tolerated Dose
Middle Aged
Neoplasms -- drug therapy
Neoplasms -- pathology
Pyridines -- administration & dosage
Pyridines -- adverse effects
Pyridines -- pharmacokinetics
Risk Assessment
Sensitivity and Specificity
Treatment Outcome
Note : Clinical Trial
Clinical Trial, Phase I
Journal Article
Multicenter Study
Langue :
  • Anglais
Identificateurs : urn:issn:0923-7534 
info:pmid/12453862